Welcome to our dedicated page for Concentra Group Holdings Parent SEC filings (Ticker: CON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Concentra Group Holdings Parent, Inc. filings document the public reporting of a NYSE-listed occupational health services company with common stock registered under the symbol CON. Recent Form 8-K disclosures cover results of operations and financial condition, Regulation FD presentations, dividend declarations, preliminary operating metrics, and material executive and compensation matters.
The company's proxy and annual-meeting filings disclose board elections, advisory executive compensation votes, auditor ratification, stockholder voting results, and governance procedures. Other filings describe executive equity awards under the 2024 Equity Incentive Plan, leadership succession disclosures, and the company's Delaware corporate and capital-stock structure.
Concentra Group Holdings Parent, Inc. (CON) disclosed new executive equity awards. On November 4, 2025, the Board’s Human Capital and Compensation Committee granted restricted shares to the company’s named executive officers under the 2024 Equity Incentive Plan. These restricted stock awards vest in equal installments on each of the first four anniversaries of the grant date.
Grants by executive:
- W. Keith Newton: 225,000 shares
- Matthew T. DiCanio: 180,000 shares
- John A. deLorimier: 60,000 shares
- John Anderson: 60,000 shares
- Michael Kosuth: 60,000 shares
- Su Zan Nelson: 60,000 shares
The awards are time-based and align compensation with multi-year service and performance horizons via four-year ratable vesting.
Concentra Group Holdings Parent, Inc. (CON) reported a Form 4 showing an equity award to an executive. On 11/04/2025, the officer received 40,000 shares of restricted stock at $0. The grant will vest in equal annual installments over four years. After this transaction, the reporting person beneficially owned 80,098 shares, held directly. The executive’s title is Executive Vice President, Chief Operating Officer Onsite Health & Telemedicine.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award. On 11/04/2025, a company officer received 60,000 shares of restricted stock at $0, increasing directly held common stock to 120,000 shares after the transaction. The award will vest in equal annual installments over four years.
The reporting person serves as Executive Vice President, Chief Operating Officer - East. This filing reflects a compensation grant rather than an open‑market purchase.
Concentra Group Holdings Parent, Inc. disclosed an officer equity award on Form 4. The President & Chief Financial Officer received 180,000 shares of restricted common stock on 11/04/2025 at a reported price of $0. The award will vest in equal annual installments over four years.
Following this grant, the officer’s beneficial ownership stands at 360,000 shares, held directly. This filing reflects routine executive equity compensation designed to align leadership with shareholders through multi‑year vesting.
Concentra Group Holdings Parent, Inc. reported a Form 4 showing an officer received a grant of 60,000 shares of common stock on November 4, 2025 at $0, increasing beneficial ownership to 120,000 shares, held directly. The award is restricted stock that vests in equal annual installments over four years. The officer’s title is Executive Vice President, Chief Clinical Services Officer.
Concentra Group Holdings Parent, Inc. (CON) disclosed a Form 4 showing a director acquired 7,748 shares of common stock as a restricted stock grant on November 4, 2025.
The restricted stock will vest in full on November 4, 2026, subject to certain exceptions. Following the transaction, the reporting person beneficially owns 74,000 shares directly. The grant was reported at a price of $0 per share.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award. The company’s Chief Executive Officer and Director acquired 225,000 shares of common stock on 11/04/2025 via a grant coded “A”. The filing lists a $0 price, consistent with a restricted stock award.
The award is described as restricted stock that will vest in equal annual installments over four years. Following this transaction, the reporting person beneficially owned 482,831 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award. Executive Vice President & Chief Legal Counsel Timothy F. Ryan acquired 60,000 shares of common stock on 11/04/2025 as a restricted stock grant at $0.
The award will vest in equal annual installments over four years. Following the grant, Ryan beneficially owned 120,000 shares, held directly.
Concentra Group Holdings Parent (CON) reported a director equity award on a Form 4. On November 4, 2025, the director received two grants of common stock: 7,748 shares that vest in equal annual installments over five years, and 7,748 shares that vest in full on November 4, 2026, subject to certain exceptions. The reported transaction price was $0, reflecting restricted stock awards. Following these grants, the director beneficially owns 15,496 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity grant. On November 4, 2025, an officer acquired 60,000 shares of common stock as a restricted stock award at $0, scheduled to vest in equal annual installments over four years.
After this grant, the reporting person beneficially owns 120,000 shares, held directly. The officer’s title is Executive Vice President, Chief Operating Officer - West.